ATRA - Atara Biotherapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts7577
Avg. Estimate-1.31-1.39-4.76-5.54
Low Estimate-1.46-1.6-4.94-6.82
High Estimate-1.12-1.22-4.16-4.47
Year Ago EPS-1.15-1.05-4-4.76
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts6366
Avg. EstimateN/AN/AN/A300k
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A1.8M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2017-12-302018-03-302018-06-292018-09-29
EPS Est.-1.14-0.92-0.98-1.13
EPS Actual-1.15-1.05-1.15-1.29
Difference-0.01-0.13-0.17-0.16
Surprise %-0.90%-14.10%-17.30%-14.20%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-1.31-1.39-4.76-5.54
7 Days Ago-1.31-1.39-4.76-5.54
30 Days Ago-1.31-1.39-4.76-5.54
60 Days Ago-1.31-1.39-4.76-5.54
90 Days Ago-1.15-1.27-4.45-4.92
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesATRAIndustrySectorS&P 500
Current Qtr.-13.90%N/AN/A0.12
Next Qtr.-32.40%N/AN/A0.04
Current Year-19.00%N/AN/A0.18
Next Year-16.40%N/AN/A0.08
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A